Table S1 from Camrelizumab Plus Famitinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: Data from an Open-label, Multicenter Phase II Basket StudyYuanyuan Qu,Hailiang Zhang, Guo H,Hong Luo,Qing Zou,Nianzeng Xing,Shujie Xia,Zhongquan Sun,Xuepei Zhang, Chao‐Hong He, Jianguo Cai, Xiao Zhang,Quanren Wang,Dingwei Yeopenalex（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
